Qinqin Zhang1, Fang Zheng2, Elie H Motulsky2, Giovanni Gregori2, Zhongdi Chu1, Chieh-Li Chen1, Chunxia Li1, Luis de Sisternes3, Mary Durbin3, Philip J Rosenfeld2, Ruikang K Wang1,2,3,4. 1. Department of Bioengineering, University of Washington, Seattle, Washington, United States. 2. Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States. 3. Advanced Development, Carl Zeiss Meditec, Inc., Dublin, California, United States. 4. Department of Ophthalmology, University of Washington Eye Institute, Seattle, Washington, United States.
Abstract
Purpose: To achieve reproducible imaging of the choriocapillaris and associated flow voids using swept-source OCT angiography (SS-OCTA). Methods: Subjects were enrolled and SS-OCTA was performed using the 3 × 3 mm scan pattern. Blood flow was identified using the complex optical microangiography (OMAG) algorithm. The choriocapillaris was defined as a slab from the outer boundary of Bruch's membrane (BM) to approximately 20 μm below BM. Compensation for the shadowing effect caused by the RPE and BM complex on the choriocapillaris angiogram was achieved by using the structural information from the same slab. A thresholding method to calculate the percentage of flow voids from a region was developed based on a normal database. Results: Twenty normal subjects and 12 subjects with drusen were enrolled. SS-OCTA identified the choriocapillaris in normal subjects as a lobular plexus of capillaries in the central macula and the lobular arrangement became more evident toward the periphery. In all eyes, signal compensation resulted in fewer choriocapillaris flow voids with improved repeatability of measurements. The best repeatability for the measurement was achieved by using 1 standard deviation (SD) for the thresholding strategy. Conclusions: SS-OCTA can image the choriocapillaris in vivo, and the repeatability of flow void measurements is high in the presence of drusen. The ability to image the choriocapillaris and associated flow voids should prove useful in understanding disease onset, progression, and response to therapies.
Purpose: To achieve reproducible imaging of the choriocapillaris and associated flow voids using swept-source OCT angiography (SS-OCTA). Methods: Subjects were enrolled and SS-OCTA was performed using the 3 × 3 mm scan pattern. Blood flow was identified using the complex optical microangiography (OMAG) algorithm. The choriocapillaris was defined as a slab from the outer boundary of Bruch's membrane (BM) to approximately 20 μm below BM. Compensation for the shadowing effect caused by the RPE and BM complex on the choriocapillaris angiogram was achieved by using the structural information from the same slab. A thresholding method to calculate the percentage of flow voids from a region was developed based on a normal database. Results: Twenty normal subjects and 12 subjects with drusen were enrolled. SS-OCTA identified the choriocapillaris in normal subjects as a lobular plexus of capillaries in the central macula and the lobular arrangement became more evident toward the periphery. In all eyes, signal compensation resulted in fewer choriocapillaris flow voids with improved repeatability of measurements. The best repeatability for the measurement was achieved by using 1 standard deviation (SD) for the thresholding strategy. Conclusions: SS-OCTA can image the choriocapillaris in vivo, and the repeatability of flow void measurements is high in the presence of drusen. The ability to image the choriocapillaris and associated flow voids should prove useful in understanding disease onset, progression, and response to therapies.
Authors: WooJhon Choi; Eric M Moult; Nadia K Waheed; Mehreen Adhi; ByungKun Lee; Chen D Lu; Talisa E de Carlo; Vijaysekhar Jayaraman; Philip J Rosenfeld; Jay S Duker; James G Fujimoto Journal: Ophthalmology Date: 2015-10-17 Impact factor: 12.079
Authors: Qinqin Zhang; Chieh-Li Chen; Zhongdi Chu; Fang Zheng; Andrew Miller; Luiz Roisman; Joao Rafael de Oliveira Dias; Zohar Yehoshua; Karen B Schaal; William Feuer; Giovanni Gregori; Sophie Kubach; Lin An; Paul F Stetson; Mary K Durbin; Philip J Rosenfeld; Ruikang K Wang Journal: Invest Ophthalmol Vis Sci Date: 2017-03-01 Impact factor: 4.799
Authors: Boy Braaf; Kari V Vienola; Christy K Sheehy; Qiang Yang; Koenraad A Vermeer; Pavan Tiruveedhula; David W Arathorn; Austin Roorda; Johannes F de Boer Journal: Biomed Opt Express Date: 2012-12-11 Impact factor: 3.732
Authors: WooJhon Choi; Kathrin J Mohler; Benjamin Potsaid; Chen D Lu; Jonathan J Liu; Vijaysekhar Jayaraman; Alex E Cable; Jay S Duker; Robert Huber; James G Fujimoto Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240
Authors: Jia Qin; Nicholas Rinella; Qinqin Zhang; Hao Zhou; Jessica Wong; Michael Deiner; Austin Roorda; Travis C Porco; Ruikang K Wang; Daniel M Schwartz; Jacque L Duncan Journal: Invest Ophthalmol Vis Sci Date: 2018-12-03 Impact factor: 4.799
Authors: Tristan T Hormel; Jie Wang; Steven T Bailey; Thomas S Hwang; David Huang; Yali Jia Journal: Biomed Opt Express Date: 2018-11-26 Impact factor: 3.732
Authors: Yingying Shi; Qinqin Zhang; Fang Zheng; Jonathan F Russell; Elie H Motulsky; James T Banta; Zhongdi Chu; Hao Zhou; Nimesh A Patel; Luis de Sisternes; Mary K Durbin; William Feuer; Giovanni Gregori; Ruikang K Wang; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2019-09-25 Impact factor: 5.258
Authors: Hao Zhou; Yining Dai; Giovanni Gregori; Philip R Rosenfeld; Jacque L Duncan; Daniel M Schwartz; Ruikang K Wang Journal: Biomed Opt Express Date: 2020-03-06 Impact factor: 3.732
Authors: Hao Zhou; Yining Dai; Yingying Shi; Jonathan F Russell; Cancan Lyu; Jila Noorikolouri; William J Feuer; Zhongdi Chu; Qinqin Zhang; Luis de Sisternes; Mary K Durbin; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Ophthalmol Retina Date: 2019-10-01